Improved survival of poor-risk non-seminomatous germ cell tumor patients: real-world data from a single institute in Japan.

Kozaburo TanumaKoji KawaiSatoshi NittaMasanobu ShigaTakashi KawaharaHiromitsu NegoroMizuki OnozawaTakamitsu InoueHiroyuki NishiyamaJun Miyazaki

Published in: Japanese journal of clinical oncology (2022)

The survival of our poor prognosis non-seminomatous germ cell tumor patients improved over time. The 5-year overall survival of patients treated in 2000-18 reached 85%.

Keyphrases

germ cell
poor prognosis
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
machine learning
free survival
electronic health record
deep learning
big data
data analysis